SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Tabletting, coating & ancillary equipment

News headlines

Catalent to assess resveratrol formulation across softgel platforms

11-Jan-2017 - Catalent will assess Jupiter Orphan Therapeutics’ resveratrol across its softgel technologies in an effort to improve the bioavailability of the rare disease candidate.

T-ray technique faster for tablet quality and structure testing say researchers

11-Jan-2017 - High frequency radiation can be used to test tablet quality and structural characteristics on the production line according to scientists planning to develop low cost THz sensors. 

US DEA finalises controlled substance and equipment revisions

09-Jan-2017 - Drugmakers must include a transaction identification number when buying or selling machinery for tabletting or encapsulating controlled substances, according to a final ruling from the US DEA.

Spain's Idifarma adds capsule filling to service offerings

01-Dec-2016 - Idifarma has invested over €300,000 in its facility in Spain in order to offer its customers automated capsule filling for commercial batches.

Catalent adding OTC capsule maker Accucaps to global softgel network

28-Nov-2016 - Catalent will add two Canadian manufacturing facilities to its softgel network through the acquisition of Accucaps.

Evonik to construct second Alabama facility for drug delivery polymers

23-Nov-2016 - Evonik has laid plans to expand a polymer facility in Alabama to cater for growing demand for sophisticated drug delivery and medical devices.

Sanofi insulin buy back and rival price hikes a boon for MannKind's Afrezza

14-Nov-2016 - Despite requiring more API, the price of inhaled insulin Afrezza has dropped below that of injected rapid-acting rivals says MannKind's CEO, reporting a resilient Q3.

Slovakian CDMO Saneca ups capabilities after controlled release contract win

10-Nov-2016 - Saneca Pharma will invest in its manufacturing site in Slovakia to service a five-year agreement supplying the Menarini Group with controlled release pellets.

GSK exiting Australian OTC site: over 200 jobs to be lost

07-Nov-2016 - GSK says it remains dedicated to Australian despite announcing plans to shutter a painkiller manufacturing site in Sydney.

Datwyler injects CHF 100m into US drug delivery component site

03-Nov-2016 - Increasing demand for reduced particle loads in pharmaceutical containers has driven Datwyler to build a CHF 100m plant making elastomer components for injectable drug delivery systems.

Everstone Capital buys stake in Rubicon Research citing delivery techs and ANDAs

25-Oct-2016 - Everstone Capital has acquired a 70% stake in drug delivery tech firm Rubicon Research Pvt for $33m (€30m).

Roller compactor bolsters Juniper's granulation capabilities

17-Oct-2016 - CDMO Juniper Pharma Services has added a small-scale roller compactor as the latest investment in its enabling technology offerings.

Aralez buys rights to AZ heart drug; encouraged by generic quality issues

10-Oct-2016 - AstraZeneca will supply Toprol-XL to Aralez Pharmaceuticals Trading for at least 10 years after selling the US rights to the off-patent beta blocker for $175m.

Dispatches from CPhI Worldwide 2016

Capsugel: enteric polymer comprising tech can speed-up drug development

04-Oct-2016 - Capsugel’s Vcaps Enteric offering can speed up development of delayed release drugs by removing the need for an additional enteric film coat, the firm says.

Barcelona welcomes API manufacturers and pharma firms

03-Oct-2016 - in-Pharmatechnologist.com is in Barcelona to hear about market and regulatory developments in the API and CMO sectors. Check back for updates.

US FDA: Cheng Fong Chemical must do more to investigate complaints

28-Sep-2016 - Cheng Fong Chemical has addressed problems at its Taoyuan City plant but still needs to identify the source of foreign matter found in its APIs according to the US FDA.

BD injects $100m into Nebraska insulin syringe plant

27-Sep-2016 - Becton Dickinson says it is upgrading equipment and technology at its Holdrege manufacturing facility to better serve the global diabetes market.

US FDA warns against $30 DIY alternative to Mylan's EpiPen

22-Sep-2016 - The US FDA has warned people not to use a $30 DIY epinephrine delivery device developed after Mylan increased the price of the Epipen.

Colorcon and Dow extend controlled release alliance

22-Sep-2016 - Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.

Sartorius pledges to cut development times with upstream suite

22-Sep-2016 - Sartorius Stedim Biotech claims it has a platform that can help biopharma companies carve months off the development time for new products.

Related News

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Product Innovation